Melatonin modulates the cadmium-induced expression of MT-2 and MT-1 metallothioneins in three lines of human tumor cells (MCF-7, MDA-MB-231 and HeLa)

Toxicology Letters

Volumn 181, Issue 3, 2008, Pages 190-195

  Alonso Gonzalez, Carolina ^a   Mediavilla, Dolores ^a   Martinez Campa, Carlos ^a   Gonzalez, Alicia ^a   Cos, Samuel ^a   Sanchez Barcelo, Emilio J ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Cadmium; HeLa; MCF 7; MDA MB 231; Melatonin; Metallothioneins

Indexed keywords

CADMIUM; MELATONIN; METALLOTHIONEIN I; METALLOTHIONEIN II;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER GRADING; CELL INVASION; CELL PROTECTION; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CELL TYPE; CONTROLLED STUDY; CYTOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANTIOXIDANTS; CADMIUM CHLORIDE; CELL LINE, TUMOR; ENVIRONMENTAL POLLUTANTS; HELA CELLS; HUMANS; MELATONIN; METALLOTHIONEIN; RNA, MESSENGER;

NICOTIANA TABACUM;

EID: 52049097319     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.07.021     Document Type: Article

References (50)

1. Abdel-Mageed A.B., and Agrawal K.C. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther. 4 (1997) 199-207
2. Alonso-Gonzalez C., Gonzalez A., Mazarrasa O., Guezmes A., Sanchez-Mateos S., Martinez-Campa C., Cos S., Sanchez-Barcelo E.J., and Mediavilla M.D. Melatonin prevents the estrogenic effects of sub-chronic administration of cadmium on mice mammary glands and uterus. J. Pineal Res. 42 (2007) 403-410
3. Barnes N.L., Ackland M.L., and Cornish E.J. Metallothionein isoform expression by breast cancer cells. Int. J. Biochem. Cell Biol. 32 (2000) 895-903
4. Bay B.H., Jin R., Huang J., and Tan P.H. Metallothionein as a prognostic biomarker in breast cancer. Exp. Biol. Med. (Maywood) 231 (2006) 1516-1521
5. Brama M., Gnessi L., Basciani S., Cerulli N., Politi L., Spera G., Mariani S., Cherubini S., Scotto d'Abusco A., Scandurra R., and Migliaccio S. Cadmium induces mitogenic signaling in breast cancer cell by an ERα-dependent mechanism. Mol. Cell. Endocrinol. 264 (2007) 102-108
6. Cavigelli M., Kagi J.H.R., and Hunziker P.E. Cell and inducer-specific accretion of human isometallothioneins. Biochem. J. 292 (1993) 551-554
7. Chwełatiuk E., Włostowski T., Krasowska A., and Bonda E. Melatonin increases tissue accumulation and toxicity of cadmium in the bank vole (Clethrionomys glareolus). Biometals 18 (2005) 283-291
8. Chwełatiuk E., Włostowski T., Krasowska A., and Bonda E. The effect of orally administered melatonin on tissue accumulation and toxicity of cadmium in mice. J. Trace Elem. Med. Biol. 19 (2006) 259-265
9. Darbre P.D. Environmental oestrogens, cosmetics and breast cancer. Best Pract. Res. Clin. Endocrinol. Metab. 20 (2006) 121-143
10. Eybl V., Kotyzova D., and Koutensky J. Comparative study of natural antioxidants-curcumin, resveratrol and melatonin in cadmium-induced oxidative damage in mice. Toxicology 225 (2006) 150-215
11. Fan L.Z., and Cherian M.G. Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. Br. J. Cancer 87 (2002) 1019-1026
12. Fresno M., Wu W., Rodriguez J.M., and Nadji M. Localization of metallothionein in breast carcinomas. An immunohistochemical study. Virchows Arch. A. Pathol. Anat. Histopathol. 423 (1993) 215-219
13. Friedline J.A., Garret S.H., Somji S., Todd J.H., and Sens D.A. Differential expression of the MT1-E gene in estrogen-receptor-positive and negative human breast cancer cells lines. Am. J. Pathol. 152 (1998) 23-27
14. Goulding H., Jasani B., Pereira H., Reid A., Galea M., Bell J.A., Elston C.W., Robertson J.F., Blamey R.W., Nicholson R.A., Schmid K.W., and Ellis I.O. Metallothionein expression in human breast cancer. Br. J. Cancer 72 (1995) 968-972
15. Gurel V., Sens D.A., Somji S., Garrett S.H., Weiland T., and Sens M.A. Post-transcriptional regulation of metallothionein isoform 1 and 2 expression in the human breast and the MCF-10A cell line. Toxicol. Sci. 85 (2005) 906-915
16. Hamer D.H. Metallothionein. Ann. Rev. Biochem. 55 (1986) 913-951
17. Huff J., Lunn R.M., Waalkes M.P., Tomatis L., and Infante P.F. Cadmium-induced cancers in animals and in humans. Int. J. Occup. Environ. Health 13 (2007) 202-212
18. Jahroudi N., Foster R., Price-Haughey J., Beitel G., and Gedamu L. Cell-type specific and differential regulation of the human metallothionein genes. Correlation with DNA methylation and chromatin structure. J. Biol. Chem. 265 (1990) 6506-6511
19. Jin R., Bay B.H., Chow V.T., Tan P.H., and Lin V.C. Metallothionein 1E mRNA is highly expressed in estrogen receptor-negative human invasive ductal breast cancer. Br. J. Cancer 83 (2000) 319-323
20. Jin R., Bay B.H., Chow V.T., and Tan P.H. Metallothionein 1F mRNA expression is correlated with histological grade in breast carcinoma. Breast Cancer Res. Treat. 66 (2000) 265-272
21. Jin R., Chow V.T., Tan P.H., Dheen S.T., Duan W., and Bay B.H. Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis 23 (2002) 81-86
22. Jin R., Huang J., Tan P.H., and Bay B.H. Clinicopathological significance of metallothioneins in breast cancer. Pathol. Oncol. Res. 10 (2004) 74-79
23. Johnson M.D., Kenney N., Stoica A., Hilakivi-Clarke L., Singh B., Chepko G., Clarke R., Sholler P.F., Lirio A.A., Foss C., Reiter R., Trock B., Paik S., and Martin M.B. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat. Med. 9 (2003) 1081-1084
24. Kagi J.H.R. Evolution, structure and chemical activity of class I metallothioneins: an overview. In: Suzuki K.T., Imura N., and Kimura M. (Eds). Metallothionein III: Biological Roles and Medical Implications, (1993), Birkhauser, Berlin 29-56
25. Karbownik M., Gitto E., Lewinski A., and Reiter R.J. Induction of lipid peroxidation in hamster organs by the carcinogen cadmium: melioration by melatonin. Cell Biol. Toxicol. 17 (2001) 3340
26. Kim C.Y., Lee M.J., Lee S.M., Lee W.C., and Kim J.S. Effect of melatonin on cadmium-induced hepatotoxicity in male Sprague-Dawley rats. Tohoku J. Exp. Med. 186 (1998) 205-213
27. Klaassen C.D., Liu J., and Choudhuri S. Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 267-294
28. Limson J., Nyokong T., and Daya S. The interaction of melatonin and its precursors with aluminium, cadmium, copper, iron, lead, and zinc: an adsorptive voltammetric study. J. Pineal Res. 24 (1998) 15-21
29. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
30. Martinez-Campa C., Alonso-Gonzalez C., Mediavilla M.D., Cos S., Gonzalez A., Ramos S., and Sanchez-Barcelo E.J. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium. J. Pineal Res. 40 (2006) 291-296
31. Martinez-Campa C.M., Alonso-Gonzalez C., Mediavilla M.D., Cos S., Gonzalez A., and Sanchez-Barcelo E.J. Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells. Cancer Lett. 268 (2008) 272-277
32. Méplan C., Mann K., and Hainaut P. Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells. J. Biol. Chem. 274 (1999) 31663-31670
33. Miura N., and Koizumi S. Heavy metal responses of the human metallothionein isoform genes. Yakugaku Zasshi 127 (2007) 665-673
34. Nath R., Kambadur R., Gulati S., Paliwal V.K., and Sharma M. Molecular aspects, physiological function and clinical significance of metallothioneins. CRC Crit. Rev. Food Sci. Nutr. 27 (1988) 41-85
35. Ostrakhovitch E.A., Olsson P.E., von Hofsten J., and Cherian M.G. P53 mediated regulation of metallothionein transcription in breast cancer cells. J. Cell. Biochem. 102 (2007) 1571-1583
36. Poliandri A.H., Esquifino A.I., Cano P., Jimenez V., Lafuente A., Cardinali D.P., and Duvilanski B.H. In vivo protective effects of melatonin on cadmium-induced changes in redox balance and gene expression in rat hypothalamus and anterior pituitary. J. Pineal Res. 41 (2006) 238-246
37. Quaife C., Findley S.D., Erickson J.C., Kelly E.J., Zambrowicz B.P., and Palmiter R.D. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 33 (1994) 7250-7259
38. Samson S.L., and Gedamu L. Molecular analyses of metallothionein gene regulation. Prog. Nucleic Acids Res. Mol. Biol. 59 (1998) 257-288
39. Sanchez-Barcelo E.J., Cos S., Mediavilla M.D., Martinez-Campa C., Gonzalez A., and Alonso-Gonzalez C. Melatonin-estrogen interactions in breast cancer. J. Pineal Res. 38 (2005) 217-222
40. Satarug S., and Moore M.R. Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ. Health Perspect. 112 (2004) 1099-1103
41. Sogawa N., Sogawa C.A., Oda N., Fujioka T., Onodera K., and Furuta H. The effects of ovariectomy and female sex hormones on hepatic metallothionein-I gene expression after injection of cadmium chloride in mice. Pharmacol. Res. 44 (2001) 53-57
42. Stohs S.J., and Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic. Biol. Med. 18 (1995) 321-336
43. Tai S.K., Tan O.J., Chow V.T., Jin R., Jones J.L., Tan P.H., Jayasurya A., and Bay B.H. Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant. Am. J. Pathol. 163 (2003) 2009-2019
44. Tan D.X., Manchester L.S., Terron M.P., Flores R.J., and Reiter R.J. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?. J. Pineal Res. 42 (2007) 28-42
45. Thirumoorthy N., Manisenthil Kumar K.T., Shyam Sundar A., Panayappan L., and Chatterjee M. Metallothionein: an overview. World J. Gastroenterol. 13 (2007) 993-996
46. Uchida Y., Takio K., Titani K., Ihara Y., and Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 7 (1991) 337-347
47. Valko M., Morris H., and Cronin M.T. Metals, toxicity and oxidative stress. Curr. Med. Chem. 12 (2005) 1161-1208
48. West A.K., Stallings R., Hildebrand C.E., Chiu R., Karin M., and Richards M.I. Human metallothionein genes: structure of the functional locus at 16q13. Genomics 8 (1990) 513-518
49. Włostowski T., Chwełatiuk E., Bonda E., Krasowska A., and Zukowski J. Hepatic and renal cadmium accumulation is associated with mass-specific daily metabolic rate in the bank vole (Clethrionomys glareolus). Comp. Biochem. Physiol. C Toxicol. Pharmacol. 141 (2005) 15-19
50. Zhang R., Zhang H., Wei H., and Luo X. Expression of metallothionein in invasive ductal breast cancer in relation to prognosis. J. Environ. Pathol. Toxicol. Oncol. 19 (2000) 95-97